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In this report, classical swine fever virus (CSFV) NS5A inhibit viral RNA replication when its
concentration reached and surpassed the level of NS5B. Three amino acid fragments of CSFV NS5A,
137–172, 224–268 and 390–414 individually were shown to be essential to NS5B binding. The former
two fragments were independently necessary for regulation of viral RNA replication and correlated
with NS5B and 30UTR binding activity. We also found that amino acids W143, V145, P227, T246, P257,
K399, T401, E406 and L413 of CSFV NS5A were essential to NS5B binding activity. Furthermore, these
amino acids were shown to be necessary for viral RNA replication and infection and conserved in NS5A
proteins of CSFV, BDV, BVDV and HCV. These results indicated that NS5A may regulate viral RNA
replication by binding to NS5B and 30UTR. NS5A can still regulate viral RNA synthesis through binding
to 30UTR when binding to NS5B is not available.
& 2012 Published by Elsevier Inc.Introduction
Classical swine fever virus (CSFV) is a small enveloped virus,
which is an important pathogen of pigs, and often causes major
losses in stock farming. CSFV is a member of the genus Pestivirus,
(family Flaviviridae) along with bovine viral diarrhea virus 1
(BVDV-1), BVDV-2, and border disease virus (BDV) (Heinz et al.,
2000; Becher and Thiel, 2002). The hepatitis C virus (HCV), the
major cause of transfusion-associated hepatitis, also belongs to
this family (Cuthbert, 1994). The CSFV genome consists of a single
plus-strand RNA containing a single large open reading frame
(ORF), a 50untranslated region (UTR) and a 30UTR. The ORF codes
for a resulting polyprotein that is subsequently processed into
mature proteins by cellular and viral proteases (Npro, C, Erns,
E1, E2, p7, NS2, NS3, NS4A, NS4B, NS5A, NS5B) (Moennig and
Plagemann, 1992). The 30UTR and the 50UTR are thought to
regulate Pestivirus genome replication (Isken et al., 2003, 2004;
Xiao et al., 2004; Pankraz et al., 2005). An internal ribosome entry
site (IRES), located in the 50UTR, is responsible for translation
initiation of viral genomes, which involves internal attachment of
the ribosomes to the initiation codon in a prokaryotic-like mode
without scanning from the 50 terminus (Fletcher and Jackson,
2002; Xiao et al., 2011).Elsevier Inc.The CSFV NS5B protein has RNA-dependent RNA polymerase
(RdRp) activity and is able to bind its cognate 30UTR and initiates
genome replication (Steffen et al., 1999; Xiao et al., 2004). RdRp is
a key enzyme of CSFV and required for replication of the positive-
strand RNA genome. NS5B transcribes the genome into negative-
sense strands, which serve as templates to produce more posi-
tive-sense RNAs for packaging into progeny viral capsids (Gong
et al., 1996). Furthermore, nucleotidyl transferase activity was
observed with CSFV NS5B (Xiao et al., 2004). In addition, CSFV
NS5B has been found to signiﬁcantly enhance the stimulative
effect of NS3 on both IRES-mediated and cellular translation (Xiao
et al., 2008). The CSFV NS5A protein comprises 497 amino acids.
Mutation analysis in the CSFV genome has indicated the impor-
tance of the conserved sequence C2717–C2740–C2742–C2767 in
NS5A for CSFV growth and viral RNA synthesis (Sheng et al.,
2010). BVDV NS5A is a replicase component that can be com-
plemented in trans (Grassmann et al., 2001). HCV NS5A has also
been shown to be an essential replicase component, and its
defective form can also be complemented in trans (Appel et al.,
2005). Data from our recent experiments in viral rescue and
recovery of viral RNA synthesis showed that CSFV NS5A, but not
NS5B nor NS3, can be trans-complemented (Sheng et al., 2010). It
has been reported that NS5B and NS5A are essential components
of replication complex (Shirota et al., 2002; Gosert et al., 2003;
Tellinghuisen et al., 2004, 2006). Data from infection studies
revealed that BVDV and HCV NS5A and yellow fever ﬂavivirus
NS5 are phosphorylated by serine/threonine kinases (Reed et al.,
Y. Chen et al. / Virology 432 (2012) 376–388 3771998). HCV NS5A has been shown to be a prerequisite for HCV
particle production as a result of its interaction with the viral
capsid protein. Alanine substitutions for the C-terminal serine
cluster in domain III of NS5A impaired NS5A basal phosphoryla-
tion, leading to a marked decrease in NS5A-core interaction,
disturbance of the subcellular localization of NS5A, and disruption
of virion production (Masaki et al., 2008). The CSFV NS5A protein
has been shown to decrease IRES-mediated translation in a dose-
dependent manner (Xiao et al., 2009). Recently, HCV NS5A has
been found to modulate NS5B RdRp activity (Shirota et al., 2002;
Quezada and Kane, 2009). In addition, HCV NS5A plays a role in
regulating viral and cellular mRNA translation (He et al., 2003;
Kalliampakou et al., 2005; Wu et al., 2008). However, the exact
function of NS5A in the life cycle of CSFV remains poorlyFig. 1. Modulation of viral RNA synthesis by NS5A. RdRp assays containing NS5B (
respectively) were performed in the presence of the RNA1 template (left panel) and
synthesized RNA was determined by real-time RT-PCR. To normalize data, the amount o
in the absence of NS5A under the same conditions. The upper panel shows the construc
RNA1 represents the 603 nt RNA template consisting of the full-length CSFV 30UTR and
template consisting of the full-length CSFV 50UTR, 30UTR and the subsequent codin
experiments.
Fig. 2. (A) Schematic of the CSFV NS5A protein and its mutant forms. ND28, ND85, ND1
28, 85, 136 and 172 amino acids, respectively. CD53, CD83 and CD108 indicate the tru
respectively. D137–172, D173–223, D224–268, D269–282, D283–334, D335–389 and D3
NS5B binding activity, 30UTR binding activity and replication regulatory activity of th
interactions. NS5A (WT or mutant) was mixed with GST-NS5B immobilized on GST re
bound protein was determined by Western blot analysis with anti-NS5A antibody. Pur
The sizes of protein molecular mass markers are indicated on the right.understood. In this paper, mutation analysis of CSFV NS5A protein
revealed three amino acid fragments and nine key amino acids of
NS5A related to NS5B and 30UTR binding, viral RNA replication
and viral infection.Results
Deletion mutational analysis of NS5A
To investigate the role of CSFV NS5A in the viral life cycle, viral
RNA synthesis was performed in the co-presence of CSFV NS5A
and NS5B. A 603 nt RNA (designated RNA1), consisting of the full-
length CSFV 30UTR and the subsequent coding sequence, was used100 ng) and increasing amounts of NS5A (0, 3, 6, 10, 50, 100, 150 and 200 ng,
RNA2 template (right panel). After incubation at 37 1C for 1 h, quantiﬁcation of
f CSFV RNA in each sample was divided by the amount detected in the RdRp assay
ts used in the experiment. SM indicates the CSFV genome (Sheng et al., 2010), and
the subsequent coding sequence (Xiao et al., 2004), RNA2 indicates the 996 nt RNA
g sequences. All results are shown as mean7SD of at least three independent
36, and ND172 indicate the truncated NS5A proteins with a deletion of N-terminal
ncated NS5A proteins with a deletion of C-terminal 53, 83, and 108 amino acids,
90–414 indicate internal deletion mutants lacking corresponding amino acids. The
ese proteins are shown on the right. (B) GST pull-down analysis of NS5B–NS5A
sin (lines 2–16, upper panel). GST protein alone served as a control (lane 1). Each
iﬁed WT and mutant NS5A proteins were used as positive controls (below panel).
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nucleotidyl transferase inﬂuencing RdRp activity, we used an RNA
template with an oxidised 30-terminal hydroxyl group (Xiao et al.,
2006). Quantiﬁcation of synthesized RNA was determined by real-
time RT-PCR. To normalize data, the amount of CSFV RNA in each
sample was divided by the amount detected in the RdRp assay in
the absence of NS5A under the same conditions. Results showed
that 3 and 6 ng of NS5A stimulated synthesis of viral RNA, while
50 to 200 ng of NS5A inhibited NS5B RdRp activity (Fig. 1).
Furthermore, a 996 nt RNA template (designated RNA2), contain-
ing the full-length CSFV 50UTR and 30UTR, was used in RdRp
assays with similar results (Fig. 1). All data suggested that CSFV
NS5A might modulate viral RNA replication through concentra-
tion changes, consistent with our recent results (Sheng et al.,
2012). To further investigate the function of CSFV NS5A, deletion
mutations of NS5A were prepared (Fig. 2A), and GST pull-down
assays were performed with these NS5A mutants. Wild type (WT)
or mutant NS5A was mixed with the NS5B bound to glutathione-
agarose (GST-NS5B). GST protein alone served as a control. ResultsFig. 3. Immunoprecipitation analysis of NS5B–NS5A interaction. PK-15 cells were
co-transfected with the pcDNA3.1 vector containing NS5B and either of the
pcDNA3.1/N-FLAG vectors containing NS5A (WT or mutant) (lanes 2, 4, 6, 8, 10,
12, 14, 16, 18, 20, 22, 24, 26, 28 and 30). As a control, PK-15 cells were also
transfected only with the pcDNA3.1/N-FLAG vector containing NS5A (WT or
mutant) (lanes 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27 and 29). Cell lysates
were immunoprecipitated using anti-NS5B antibody. Immunoprecipitation of
NS5B–NS5A was determined by Western blot analysis with anti-FLAG antibody
(upper panel) or anti-NS5B antibody (below). Total lysates were fractionated by
10% SDS-PAGE and subjected to Western blot analysis with anti-FLAG antibody
(middle). The sizes of protein molecular mass markers are indicated on the right.
Fig. 4. Modulation of viral RNA synthesis by mutant NS5A. RdRp assays containing 10
template (A) and with RNA2 template (B). Quantiﬁcation of synthesized RNA was determ
independent experiments.showed that the WT NS5A was pulled down with the GST-NS5B,
but not with the GST protein alone (Fig. 2B: lanes 1 and 2),
implying that CSFV NS5A was able to interact with NS5B. In the
same manner, we observed that ND28, ND85, ND136, CD53,
CD83, D173–223, D269–282, D283–334 and D335–389 were
pulled down with GST-NS5B, not ND172, CD108, D137–172,
D224–268 and D390–414 (Fig. 2B). To detect whether the above
reactions occurred in vivo, immunoprecipitation analyses were
performed. PK-15 cells were transiently co-transfected with the
pcDNA3.1 vector containing NS5B and the pcDNA3.1/N-FLAG
vectors containing WT or mutant NS5A. Co-precipitated proteins
were detected by Western blot analysis. Immunoprecipitation
analysis showed that WT NS5A, ND28, ND85, ND136, CD53, CD83,
D173–223, D269–282, D283–334 and D335–389 interacted with
NS5B while ND172, CD108, D137–172, D224–268 and D390–414
did not (Fig. 3). These results indicated that three discontinuous
fragments of NS5A (amino acids 137–172, 224–268 and 390–414)
were independently essential for the interaction.
To examine the effect of NS5A on viral replication, we
performed RNA replication experiments in presence of NS5A
deletion mutants with the RNA1 as a template. As shown in the
left panel of Fig. 4A, ND28, a truncated NS5A with a deletion of
the ﬁrst 28 amino acids, still bound NS5B and decreased RNA
synthesis as did WT NS5A. These results indicated that ND28
possessed NS5B-binding, replication regulatory activity, consis-
tent with previous reports, in which deletion of the ﬁrst 28 amino
acids of BVDV NS5A, a membrane anchor, failed to inhibit the role
of NS5A (Tellinghuisen et al., 2004). ND85 and ND136, lacking
N-terminal amino acids 85 and 136, maintained NS5B-binding
activity, but did not regulate viral replication. A conserved
sequence [C2717(34)–C2740(57)–C2742(59)–C2767(84)], which
constitutes a zinc-binding motif essential to the life cycle of
Pestivirus, is located in the N-terminal region, corresponding to
the deleted region of CSFV NS5A (Tellinghuisen et al., 2006; Sheng
et al., 2010). The lack of ND85 and ND136 regulation activity
might be due to the deletion of the above conserved sequence.
Interestingly, two internal deletion mutants, with defective NS5B-
binding activity (D137–172, D224–268), did not inhibit RNA
synthesis. Four internal deletion mutants (D173–223, D269–
282, D283–334, D335–389) with the NS5B-binding activity sup-
pressed replication, similar to WT NS5A (Fig. 4A). An internal
deletion mutant, D390–414, was defective in NS5B binding but
retained RNA synthesis regulating activity. Furthermore, RdRp
assays containing NS5B and mutant NS5A were performed in the
presence of the RNA2 template and similar results were observed
(Fig. 4B). These data indicated that two amino acid fragments0 ng of NS5B and 200 ng of NS5A (WT or mutant) were performed with the RNA1
ined as described in Fig. 1(A). All results are shown as mean7SD of at least three
Fig. 5. CSFV NS5A and D390–414 interact with its cognate 30UTR. (A) Cytoplasmic
extracts of PK15 cells transfected with CSFV subgenomic replicon, CSM, were
subjected to afﬁnity chromatography with biotinylated RNAs correspending to
CSFV 30UTR (nt 1–231).Western blot analysis was performed with antibodies
speciﬁc to CSFV NS5A. Lane 1 is for 30UTR–NS5A complexes, lane 2 for input, lane
3 for an irrelevant biotinylated RNA, an random sequence corresponding to
positions 1245–1700 of the CSFV plus-strand genome, lane 4 for no 30UTR RNA.
((B) and (D)) Cytoplasmic extracts of PK15 cells transfected with NS5A-expressing
vectors (B) or D390–414-expressing vectors (D) were UV-crosslinked with
biotinylated RNAs corresponding to CSFV 30UTR (lane 1). The transfected cell
extracts UV-crosslinked with the above-mentioned irrelevant biotinylated RNA
served as controls (lane 2). Analysis was performed by detection of RNA with
Bright Star Biodetect Kit (upper panel) and detection of protein with Western
blotting (below panel). ((C) and (E)) Puriﬁed NS5A (C) or D390–414 (E) were
UV-crosslinked with biotinylated RNAs corresponding to CSFV 30UTR (lane 1).
These puriﬁed proteins UV-crosslinked with the above-mentioned irrelevant
biotinylated RNA served as controls (lane 2). Analysis was performed by detection
of RNA with Bright Star Biodetect Kit (upper panel) and detection of protein with
Western blotting (below panel).
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RNA replication, correlated with NS5B binding activity, suggesting
that regulation activity of NS5A for viral RNA synthesis might
be related to NS5B binding. But, we noted that D390–414, not
binding to NS5B, still regulated viral RNA synthesis.
To further investigate the mechanism of NS5A, we examined
the 30UTR-binding activity of NS5A (WT or mutants). Afﬁnity
chromatography was ﬁrst performed using an RNA segment
corresponding to CSFV 30UTR (nt 231, GenBank AF092448).
Cytoplasmic extracts were prepared from the PK15 cells trans-
fected with CSFV subgenomic replicon CSM, a replicon that carries
a deletion of the sequence encoding amino acids 72–79 of the
core gene in the context of genomic replicon SM (Fig. 1A), which
has been shown to have an expression activity (Sheng et al.,
2010), incubated with a biotinylated CSFV 30UTR. The RNA-
protein complexes were precipitated by streptavidin-agarose
resin, followed by detection of NS5A protein by antibodies
speciﬁc to CSFV NS5A in Western blot analysis. Results showed
that CSFV NS5A bound its cognate 30UTR, and did not bind the
irrelevant biotinylated RNA (Fig. 5A). Cytoplasmic extracts of
PK15 cells transfected with NS5A-expressing vectors or puriﬁed
NS5A proteins were UV-crosslinked with biotinylated 30UTR,
subjected to detection of RNA with Bright Star Biodetect Kit, or
to detection of protein with Western blotting. The CSFV 30UTR and
NS5A were clearly detected in the two UV-crosslinking assays
(Fig. 5B and C). Direct binding of D390–414 to 30UTR was also
conﬁrmed using UV-crosslinking assays (Fig. 5D and E). These
data strongly suggested that D390–414 is directly bound to its
cognate 30UTR as its wild-type partner, regulation activity of
D390–414 for viral RNA synthesis might be related to 30UTR
binding. Other mutants binding to 30UTR were also examined
using UV-crosslinking assays as D390–414 and the results are
summarized in Fig. 2A. D137–172 and D224–268, which do not
regulate viral RNA synthesis, not binding to NS5B, also did not
interact with 30UTR. D269–282, with the regulation activity for
viral RNA synthesis and NS5B-binding activity, did not interact
with 30UTR. Taken together, regulation activity of NS5A for viral
RNA synthesis might be related to binding to NS5B and 30UTR.
When binding to NS5B is not available, NS5A can still regulate
viral RNA synthesis through binding to 30UTR.
Alanine scanning mutational analysis of NS5A
To detect important amino acids of the CSFV NS5A protein,
alanine scanning mutational analyses on the above three amino
acid fragments essential to NS5B binding were performed. The
amino acid fragment 137–172 was ﬁrst addressed. Nine mutants
(137–172D1–D9) were produced by replacing amino acid 137–172
with four continuous alanine residues within the NS5A coding
gene (Fig. 6A). GST pull-down, immunoprecipitation assays and
RNA replication experiments were performed in presence of these
NS5A mutants. Results showed that mutants 137–172D6–D8
retained NS5B-binding activity and inhibited viral RNA synthesis,
as did WT NS5A, but 137–172D1–D5 and D9 did not bind NS5B
and did not reduce viral RNA synthesis (Fig. 6B–D), indicating that
the corresponding mutant regions of 137–172D1–D5 and D9
might be important for NS5B-binding and viral RNA synthesis.
Twelve mutants (224–268D1–D12) were produced by repla-
cing amino acid 224–268 with three or four continuous alanine
residues (Fig. 7A). GST pull-down, immunoprecipitation assays
and RNA replication experiments were performed with these
NS5A mutants. We found that mutants 224–268D4, D5 and D8
still bound NS5B and reduced viral RNA synthesis as did WT type
NS5A, but 224–268D1–3, D6, D7 and D9–12 did not bind NS5B
and did not modulate viral RNA synthesis (Fig. 7B–D), suggesting
that the corresponding mutant regions of 224–268D1–3, D6, D7and D9–12 might be important for NS5B binding and viral RNA
synthesis.
We previously performed a comprehensive mutagenesis of
amino acid 390–414 of NS5A by constructing triple alanine-
scanning mutations and produced eight mutant NS5A proteins
(Xiao et al., 2009). By replacing the same amino acid 390–414,
but with ﬁrst four and then three continuous alanine residues,
seven mutants (390–414D1–D7), different from the previous
NS5A mutants, were produced (Fig. 8A). GST pull-down, immu-
noprecipitation assays and RNA replication experiments were
Fig. 6. Interaction between CSFV NS5B and the mutant forms of NS5A covering amino acid 137–172. (A) Schematic of NS5A mutant forms covering amino acid 137–172.
The names of WT and mutant NS5B proteins are shown on the left. The dotted lines (    ) represent the remainder of the NS5A sequence. The amino acids replaced
by quadruple alanine substitutions are underlined. (B) GST pull-down analysis of interactions between CSFV NS5B and the mutant forms of NS5A covering amino acid
137–172. NS5A (WT or mutants) was mixed with GST-NS5B immobilized on GST resin (lines 2–11) and detected as described in Fig. 2(B). GST protein alone served as
acontrol (lane 1). Puriﬁed WT and mutant NS5A proteins were used as positive controls (lanes 12–21). (C) Immunoprecipitation analysis of interaction between CSFV NS5B
and the mutant forms of NS5A covering amino acid 137–172. PK-15 cells were co-transfected with the pcDNA3.1 vector containing NS5B and either of the pcDNA3.1/N-FLAG
vectors containing NS5A (WT or mutant) (lanes 2, 4, 6, 8, 10, 12, 14, 16, 18 and 20) and detected as described in Fig. 3. As a control, PK-15 cells were transfected with only the
pcDNA3.1/N-FLAG vector containing NS5A (WT or mutant) (lanes 1, 3, 5, 7, 9, 11, 13, 15, 17 and 19). (D) Modulation of viral RNA synthesis with RNA1 as a template by mutant
NS5A was detected as described in Fig. 4(A). All results are shown as mean7SD of at least three independent experiments.
Y. Chen et al. / Virology 432 (2012) 376–388380performed with these NS5A mutants. We found that all of these
mutants reduced viral RNA synthesis as did WT NS5A, but did not
retained NS5B-binding activity (Fig. 8B–D), implying that all these
mutant regions of 390–414D1–D7 might be important for NS5B
binding.
Furthermore, single alanine substitution mutations were intro-
duced within the 137–172D1–D5 and D9 regions to produce 23
mutants (Table 1). GST pull-down, immunoprecipitation assays
and RNA replication experiments were performed with these
NS5A mutants. We found that all mutants retained NS5B-binding
activity and regulation activity for viral RNA synthesis, except for
137–143WA and 137–145VA (Table 1 and results not shown).
Mutants 137–143WA and 137–145VA did not bind NS5B and did
not reduce viral RNA synthesis (Fig. 9A–C), indicating that amino
acids W143 and V145 were individually necessary for NS5B
binding activity and regulation of RNA synthesis.
Individual amino acid substitutions were introduced within
the 224–268D1–3, D6, D7 and D9–12 regions and produced 31
mutants (Table 1). GST pull-down, immunoprecipitation assaysand RNA replication experiments were performed with these
NS5A mutants. We found that all mutants retained NS5B-binding
activity and regulation activity for viral RNA synthesis, except for
224–227PA, 224–246TA and 224–257PA (Table 1 and results not
shown). Mutants 224–227PA, 224–246TA and 224–257PA did not
bind NS5B and did not reduce viral RNA synthesis (Fig. 9A–C),
indicating that amino acids P227, T246 and P257 of CSFV NS5A
were individually necessary for NS5B binding activity and regula-
tion of RNA synthesis.
Single alanine substitution mutations were introduced to
the 390–414D1–D7 regions, producing 23 mutants (Table 1). In
the same manner, we found that all mutants retained regula-
tion activity for viral RNA synthesis; however, 390–399KA,
390–401TA, 390–406EA and 390–413LA did not bind NS5B
(Fig. 9A–C and results not shown). In our previous report, amino
acids K399, T401, E406 and L413 of NS5A was found to be crucial
for the inhibitory effect of the protein on CSFV IRES-directed
translation (Xiao et al., 2009). Taken together, amino acids K399,
T401, E406 and L413 of CSFV NS5A were individually necessary
Fig. 7. Interaction between CSFV NS5B and the mutant forms of NS5A covering amino acid 224–268. (A) Schematic of NS5A mutant forms covering amino acid 224–268.
The names of WT and mutant NS5B proteins are shown on the left. The dotted lines (    ) represent the remainder of the NS5A sequence. The amino acids replaced by
triple or quadruple alanine substitutions are underlined. (B) GST pull-down analysis of interaction between CSFV NS5B and the mutant forms of NS5A covering amino acid
224–268. NS5A (WT or mutants) was mixed with GST-NS5B immobilized on GST resin (lines 2–14) and detected as described in Fig. 2(B). GST protein alone served as a
control (lane 1). Puriﬁed WT and mutant NS5A proteins were used as positive controls (lanes 15–27). (C) Immunoprecipitation analysis of the interaction between CSFV
NS5B and the mutant forms of NS5A covering amino acid 224–268 was detected as described in Fig. 3. PK-15 cells were co-transfected with the pcDNA3.1 vector
containing NS5B and either of the pcDNA3.1/N-FLAG vectors containing NS5A (WT or mutant) (lanes 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24 and 26). As a control, PK-15 cells
were also transfected only with the pcDNA3.1/N-FLAG vectors containing NS5A (WT or mutant) (lanes 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23 and 25). (D) Modulation of viral
RNA synthesis with RNA1 as a template by mutant NS5A was detected as described in Fig. 4(A). All results are shown as mean7SD of at least three independent
experiments.
Y. Chen et al. / Virology 432 (2012) 376–388 381for not only regulation of IRES-mediated translation, but also
NS5B binding activity.
To examine the role of the above-mentioned nine amino acids in
infection, nine CSFV genomic replicons (SM-W143A, SM-V145A, SM-
P227A, SM-T246A, SM-P257A, SM-K399A, SM-T401A, SM-E406A and
SM-L413A) were produced by replacing corresponding amino
acids of NS5A with a single alanine, respectively, in the context
of SM-, another CSFV genomic replicon with markers prepared as
described previously (Sheng et al., 2010) (Fig. 10A). PK15 cells
were transfected by these genomic replicons, respectively. CSFV-
speciﬁc mAbs were used for detection of new virus at 48 h post-
transfection. The results showed that no virus was recovered from
these PK15 cells transfected by these genomic replicons, except
for SM- (Fig. 10B and results not shown). Similarly, PK15 cells
were transfected by nine CSFV subgenomic replicons, respec-
tively, which were produced by replacing corresponding amino
acids of NS5A with a single alanine, respectively, in the context of
CSM-, another CSFV subgenomic replicon generated through in-
frame deletion of a region encoding acid residues 240–247 of core
protein in the complete genome RNA replicons, SM (Sheng et al.,
2010). Quantiﬁcation of viral RNA was performed at the indicated
time periods. Results showed that the amount of CSFV RNAgradually increased over time in cells transfected by subgenomic
replicon CSM- and that a very low level of CSFV RNA was detected
in cells transfected by these mutated subgenomic replicons
(Fig. 11A and B and results not shown). Our previous work
showed that mutations within CSFV NS5A can be trans-comple-
mented (Sheng et al., 2010). Complementation experiments were
performed between mutated RNA replicon and expressed NS5A
protein, or between mutated subgenomic replicons and expressed
NS5A protein. Results showed that mutated RNA replicon and
mutated subgenomic replicons were trans-complemented by
expressed NS5A protein (Fig. 10C and Fig. 11C and results not
shown). All these indicated that W143, V145, P227, T246, P257,
K399, T401, E406 and L413 of NS5A are essential to viral rescue
and that these amino acids might be important for viral infection
and viral replication.Discussion
The NS5B protein is a CSFV replicase and contains a highly
conserved GDD sequence believed to be a hallmark of RdRps
(Wang et al., 2007). We have known that NS5A is necessary for
Fig. 8. Interaction between CSFV NS5B and the mutant forms of NS5A covering amino acid 390–414. (A) Schematic of NS5A mutant forms covering amino acid 390–414.
The names of WT and mutant NS5B proteins are shown on the left. The dotted lines (    ) represent the remainder of the NS5A sequence. The amino acids replaced by
quadruple or triple alanine substitutions are underlined. (B) GST pull-down analysis of interactions between CSFV NS5B and the mutant forms of NS5A covering amino acid
390–414. NS5A (WT or mutants) was mixed with GST-NS5B immobilized on GST resin (lines 2–9) and detected as described in Fig. 2(B). GST protein alone served as a
control (lane 1). Puriﬁed WT and mutant NS5A proteins were used as positive controls (lanes 10–17). (C) Immunoprecipitation analysis of interactions between CSFV NS5B
and the mutant forms of NS5A covering amino acid 390–414 was detected as described in Fig. 3. PK-15 cells were co-transfected with the pcDNA3.1 vector containing
NS5B and either of the pcDNA3.1/N-FLAG vectors containing NS5A (WT or mutant) (lanes 2, 4, 6, 8, 10, 12, 14 and 16). As a control, PK-15 cells were also transfected only
with the pcDNA3.1/N-FLAG vectors containing NS5A (WT or mutant) (lanes 1, 3, 5, 7, 9, 11, 13 and 15). (D) Modulation of viral RNA synthesis with RNA1 as a template by
mutant NS5A was detected as described in Fig. 4(A). All results are shown as mean7SD of at least three independent experiments.
Y. Chen et al. / Virology 432 (2012) 376–388382replication of viral genomes. However, the exact function of NS5A
in the life cycle of viruses remains unclear. A previous report, in
which no viral 30UTR, but rather only poly(A) and oligo(U) served
as template and primer, has shown that HCV NS5A initially
weakly stimulates (o0.1 M ratio to NS5B), then inhibits NS5B
RdRp activity. A 5–10-fold molar excess of NS5A virtually abol-
ished the RdRP activity (Shirota et al., 2002). Recently, a report
showed that HCV NS5A stimulates replication by NS5B on the
viral 30UTR template even at lower concentrations than NS5B;
however, a pre-incubation step with the two proteins prior to the
replication reaction is required (Quezada and Kane, 2009). In our
present RdRp assays, both the full-length 30UTR RNA template
and the full-length 50UTR-30UTR RNA template were used. All
results showed that small amounts of CSFV NS5A stimulated viral
RNA synthesis, but was inhibitory when its concentration reached
and surpassed the level of NS5B (Fig. 1), consistent with our
recent reports (Sheng et al., 2012). These data consistentlysupport the assertion that CSFV NS5A can modulate viral
replication.
To investigate the CSFV NS5A mechanism that modulates
NS5B RdRp activity, deletion and alanine scanning mutational
analysis of CSFV NS5A were performed and NS5B and 30UTR
binding activity and regulation activity of NS5A mutants for viral
RNA synthesis were examined. Results showed that three frag-
ments of NS5A (amino acids 137–172, 224–268 and 390–414)
were found to be independently essential for NS5B binding. The
former two fragments individually were necessary for regulation
of viral RNA synthesis while the last one was non-essential. These
results are in partial agreement with previous reports in which an
N-terminal fragment of HCV NS5A was found to be necessary,
while the C-terminal fragment was shown to be unnecessary for
HCV replication (Tellinghuisen et al., 2005, 2008). HCV NS5A
contains two discontinuous regions (amino acids 105–162 and
277–334), which are independently essential for NS5A–NS5B
Table 1
Mutant NS5A proteins produced by a single alanine substitution.
Name,a aa,b
positionc
NS5B-
binding
Replication
regulation
Name,a aa,b
positionc
NS5B-
binding
Replication
regulation
137–137IA þ þ 224–253EA þ þ
137–138LA þ þ 224–254KA þ þ
137–140TA þ þ 224–255VA þ þ
137–141DA þ þ 224–256TA þ þ
137–142KA þ þ 224–257PA  
137–143WA   224–258EA þ þ
137–144EA þ þ 224–259MA þ þ
137–145VA   224–260QA þ þ
137–146DA þ þ 224–261EA þ þ
137–147HA þ þ 224–262EA þ þ
137–148SA þ þ 224–263LA þ þ
137–149TA þ þ 224–264TA þ þ
137–150LA þ þ 224–265LA þ þ
137–151VA þ þ 224–266QA þ þ
137–152RA þ þ 224–267PA þ þ
137–153VA þ þ 390–390NA þ þ
137–154LA þ þ 390–392LA þ þ
137–155KA þ þ 390–393LA þ þ
137–156RA þ þ 390–394KA þ þ
137–169EA þ þ 390–395FA þ þ
137–170KA þ þ 390–396VA þ þ
137–171PA þ þ 390–397DA þ þ
137–172NA þ þ 390–398YA þ þ
224–224KA þ þ 390–399KA  þ
224–225EA þ þ 390–400GA þ þ
224–226IA þ þ 390–401TA  þ
224–227PA   390–402FA þ þ
224–229VA þ þ 390–403LA þ þ
224–230TA þ þ 390–404TA þ þ
224–231VA þ þ 390–405RA þ þ
224–232TA þ þ 390–406EA  þ
224–241NA þ þ 390–407TA þ þ
224–242EA þ þ 390–408LA þ þ
224–243DA þ þ 390–409EA þ þ
224–244IA þ þ 390–411LA þ þ
224–245GA þ þ 390–412SA þ þ
224–246TA   390–413LA  þ
224–247IA þ þ 390–414GA þ þ
224–248RA þ þ
a Name for mutant NS5A protein.
b Amino acid replaced with a single alanine.
c Position where substitution mutation occurs. The name 137–138LA repre-
sents the mutant NS5A protein produced by replacing amino acid ‘‘L’’ at position
138 with alanine. The mutant NS5A proteins whose names contain ‘‘137’’, ‘‘224’’
and ‘‘390’’ in front were produced in the context of WT NS5A sequences
‘‘137-ILATDKWEVDHSTLVRVLKRHTGAGYNGAYLGEKPN-172’’, ‘‘224-KEIPAVTVTTW-
LAYTFVNEDIGTIRPAFGEKVTPEMQEEITLQPA-268’’ and ‘‘390-NALLKFVDYKGTFLTRE-
TLEALSLG-414’’, respectively.
Y. Chen et al. / Virology 432 (2012) 376–388 383interaction and regulation of RdRp activity (Shirota et al., 2002).
In our present report, two fragments, amino acids 137–172 and
224–268 of CSFV NS5A, were found to be independently essential
for NS5B and 30UTR binding and regulation of RdRp activity. We
suppose that NS5A might regulate viral RNA synthesis by binding
to NS5B.
But, we found that some mutants, such as D390–414, do not
bind to NS5B, but yet regulate RNA synthesis at higher concen-
trations (Figs. 4 and 7). In addition to binding to NS5B, CSFV NS5A
might have other mechanisms to regulate viral RNA synthesis. We
have known that HCV NS5A is an RNA-binding protein that binds
to the 30ends of HCV RNAs (Huang et al., 2005). CSFV NS5A has
been found to bind to an IRES sequence (Zhu et al., 2010). The
binding of NS5A to RNA templates might be an obstacle to new
RNA synthesis by NS5B, which then regulates viral RNA synthesis.
Indeed, our experiments indicated that D390–414 is a 30UTR
binding protein, as its wild-type partner (Fig. 5). Another mutant
NS5A, D269–282, not binding to 30UTR, interacted with NS5B
and regulated viral RNA synthesis. Taken together, NS5A mightmodulate viral replication through binding to NS5B and 30UTR.
When binding to NS5B is not available, NS5A can still regulate
viral RNA synthesis through binding to 30UTR.
We also found that amino acid fragment 137–172 contains
W143 and V145, 224–268 contains P227, T246 and P257, and
390–414 contains K399, T401, E406, and L413, vital for the NS5B-
NS5A interaction. The data from alignment analysis of NS5A
protein sequences of CSFV, BDV, BVDV and HCV indicated that
all of the above-mentioned amino acids were conserved (Fig. 9D),
implying that these NS5A amino acids might be also important for
NS5B and 30UTR binding activity and regulation of viral RNA
replication in BDV, BVDV and HCV. In fact, amino acids 105–162
of HCV NS5A were essential for NS5A–NS5B interaction and
regulation of RdRp activity and partially overlapped with the
corresponding region of CSFV NS5A (Shirota et al., 2002) (Fig. 9D).
In our previous report, amino acids K399, T401, E406 and L413 of
NS5A proteins from CSFV, BVDV-1, BVDV-2, BDV and HCV were
shown to be conserved, and important for repressing IRES activity
(Xiao et al., 2009).
Furthermore, our present report showed that no virus was
rescued in these cells transfected by these genomic replicons
containing mutant NS5A, in which above nine amino acids were
replaced by a single alanine, respectively (Fig. 9), suggesting that
all the nine amino acids are necessary for efﬁcient CSFV particle
formation. We have known that NS5B and NS5A are essential
components of replication complexes and that NS5A–NS5B inter-
action is a prerequisite for replication complex formation (Shirota
et al., 2002; Gosert et al., 2003; Tellinghuisen et al., 2004;
Tellinghuisen et al., 2006). We have revealed that NS5A–NS5B
interaction is destroyed when any of the above nine amino acids
is replaced. Therefore, the reason that viruses were not rescued
might be that NS5A–NS5B interaction was destroyed and replica-
tion complex was not formed. We assume that the CSFV NS5A
protein might be bifunctional, in the sense that NS5A might
regulate viral replication and translation: regions 137–172 and
224–268 are responsible for viral replication regulation, while
region 390–414 is responsible for not only viral replication but
also translation regulation. It is understood that small amounts of
NS5A forms part of the replication complexes with NS5B through
regions 137–172, 224–268 and 390–414 to promote viral RNA
synthesis. When its concentration reached and surpassed the
level of NS5B, NS5A interacted with NS5B and 30UTR through
the three regions to inhibit viral RNA synthesis. The NS5A at
higher concentrations also bound to IRES sequences through
region 390–414 to suppress viral translation (Xiao et al., 2009),
which eventually leads to reduction in viral RNA replication. NS5A
can still regulate viral RNA replication through binding to 30UTR
when region 390–414 is destroyed and both NS5B binding and
viral translation regulation is not available.Materials and methods
Prokaryotic expression and puriﬁcation of proteins
Prokaryotic expression and puriﬁcation of NS5A and NS5B
proteins were performed as previously described (Xiao et al.,
2006). In brief, total RNA was extracted from CSFV Shimen strain.
The cDNAs encoding NS5B (amino acids 3181–3898), full-length
NS5A (WT) (amino acids 2684–3180), truncated NS5A proteins,
ND28 (amino acids 2712–3180), ND85 (amino acids 2769–3180),
ND136 (amino acids 2820–3180), ND172 (amino acids 2856–
3180), CD53 (amino acids 2684–3127), CD83 (amino acids 2684–
3097), CD108 (amino acids 2684–3072) were obtained by RT-PCR
from the genome of CSFV Shimen strain, and cloned into
the pET28(a) vector, respectively. Expression of internal deletion
Fig. 9. Interaction between CSFV NS5B and the mutant forms of NS5A replaced by a single alanine. (A) GST pull-down analysis of interaction between CSFV NS5B and the
mutant forms of NS5A replaced by a single alanine was detected as described in Fig. 2(B). NS5A (WT or mutants) was mixed with GST-NS5B immobilized on GST resin
(lines 2–11). GST protein alone served as a control (lane 1). Puriﬁed WT and mutant NS5A proteins were used as positive controls (lanes 12–21). (B) Immunoprecipitation
analysis of the interaction between CSFV NS5B and the mutant forms of NS5A replaced by single alanine was detected as described in Fig. 3. PK-15 cells were co-
transfected with the pcDNA3.1 vectors containing NS5B and either of the pcDNA3.1/N-FLAG vectors containing NS5A (WT or mutant) (lanes 2, 4, 6, 8, 10, 12, 14, 16, 18 and
20). As a control, PK-15 cells were also transfected only with the pcDNA3.1/N-FLAG vector containing NS5A (WT or mutant) (lanes 1, 3, 5, 7, 9, 11, 13, 15, 17 and 19).
(C) Modulation of viral RNA synthesis with RNA1 as a template by mutant NS5A was detected as described in Fig. 4(A). All results are shown as mean7SD of at least three
independent experiments. (D) Sequence of the NS5A protein of CSFV (GenBank accession no. AF092448) containing necessary residues for NS5B-binding activity,
regulation of viral RNA synthesis and IRES-mediated translation (indicated by ‘‘-’’) were aligned with the corresponding BDV sequences (NP_777544), BVDV-1
(NP_776270), BVDV-2 (NP_777492) and HCV (ABH10009) using CLUSTAL_X. The viral strains are indicated on the left and the NS5A amino acid numbering is indicated for
each virus. Complete sequence alignment of NS5A proteins is only partially shown (Xiao et al., 2009).
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334, D335–389, D390–414, were obtained by deletion of amino
acids 137–172, 173–223, 224–268, 269–282, 283–334, 335–389
and 390–414 from NS5A, respectively (Fig. 2A). A comprehensive
mutagenesis of amino acids 137–172, 224–268 and 390–414 was
performed by constructing individual, triple or quadruple ala-
nine-scanning mutations for the corresponding fragments. Ala-
nine substitutions were introduced by PCR ampliﬁcation of the
NS5A coding region of the genome of CSFV Shimen using primers
containing the desired changes. A His6 tag was added to the
C-terminus of each of these proteins to facilitate the puriﬁcation of
these proteins. The inserted regions of all clones were sequenced
through dideoxynucleotide sequencing and no changes were found.
These resulting plasmids were introduced into the Escherichia coli
strain BL21 (DE3) for expression driven by T7 RNA polymerase.Expression was induced by addition of isopropylthiogalactoside
(IPTG). Quantiﬁcation and puriﬁcation of proteins were performed
as previously described (Xiao et al., 2006).
To express a GST-NS5B fusion protein, the fragment encoding
NS5B was ampliﬁed by PCR, engineered a BamHI site and an XhoI
site. PCR products were digested with BamHI/XhoI and inserted into
the pGEX-4T-1 vector (Amersham Pharmacia Biotech), in frame with
the GST-encoding sequence, to generate pGEX-4T/NS5B. The GST or
GST-NS5B fusion protein was expressed in Escherichia coli BL21
(DE3), puriﬁed with glutathione-Sepharose 4B beads (Amersham
Pharmacia Biotech) according to the manufacturer’s instructions. In
brief, expression was induced by addition of IPTG. The cells from
500 mL of culture were then harvested and sonicated in 45 mL of
PBS buffer supplemented with a protease inhibitor cocktail and 1%
Triton X-100. Insoluble materials were pelleted at 15,000 g for
Fig. 10. The effect of key amino acid substitutions in NS5A on rescue of viruses. (A) The constructs used in the experiment. SM indicates CSFV genome (Sheng et al., 2010).
The proteins are shown over the SM genomic replicon. Seven fragments of cDNA covering CSFV complete genome are labeled under the SM genomic replicon.
SM- represents the CSFV genome with markers produced by site-directed mutagenesis (G9973A, C9976T, at nucleotide level) (Sheng et al., 2010). SM-W143A, SM-V145A,
SM-P227A, SM-T246A, SM-P257A, SM-K399A, SM-T401A, SM-E406A and SM-L413A represent the mutant CSFV genomes, produced by replacing corresponding amino
acids of NS5A with a single alanine, indicated by arrows. (B) Immunoﬂuorescence assay of PK15 cells transfected by different RNA replicons (SM-, SM-W143A, SM-P227A,
SM-K399A) with CSFV-speciﬁc E2 mAb and a secondary FITC-labelled antibody at 48 h post-transfection. (C) Immunoﬂuorescence assay of PK15 cells co-transfected
by RNA replicon SM-W143A and pcDNA3.1/N-FLAG-NS5A vectors (Sheng et al., 2012) with CSFV-speciﬁc E2 mAb and a secondary FITC-labelled antibody at 48 h post-
transfection.
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was added to the clariﬁed supernatants. The beads were allowed to
bind proteins for 1 h, washed three times in PBS, and ﬁnally
resuspended in 500 mL of PBS supplemented with 1% Triton X-100.
RdRp assays
RdRp assays were performed essentially as described pre-
viously (Xiao et al., 2006). Total volume was 50 mL, containing
the following supplements: 50 mM Hepes (pH 8.0), 5 mM MgCl2,
10 mM DTT, 25 mM KCl, l mM EDTA, 20 U RNasin, 50 mg actino-
mycin D (Sigma), 200 mM each NTP, 1 mL of RNA1 template
(250 ng/ml) or 2 mL of RNA2 template (250 ng/ml) (Fig. 1A),
100 ng NS5B proteins and the indicated concentration of wild
type (WT) or mutant NS5A. The mixture was incubated at 37 1C
for 1 h, and the reaction was stopped by the addition of 2 mL of
EDTA (200 mM). The reaction samples were extracted with
phenol/chloroform, and RNAs were precipitated with isopropyl
alcohol.
Quantiﬁcation of viral RNA
Viral RNA was quantiﬁed by real-time RT-PCR. Forward primer
(nucleotides 12071–12093, 50-GCGCGGGTAACCCGGGATCTGAA-30),
reverse primer (12174–12190, 50-CAGTTCTTACTCATTCA-30), and
TaqMan probe (nucleotides 12103–12124, FAM-50-AGGACCCTA-
TTGTAGATAACAC-30-TAMRA) were designed based on the 30UTR
sequence of CSFV Shimen strain (GenBank AF092448). Total
RNA was extracted from products of RdRp assays with phenol/chloroform. After ethanol precipitation, the RNA was dried, and
redissolved in 20 mL of double distilled H2O. The concentration of
RNA was determined by measuring its absorbance at 260 nm. RT
was performed using Superscript II reverse transcriptase (Invitro-
gen). The quantitative real-time PCR was run using the AbiPr-
ism7000 sequence detection system (Applied Biosystems). PCR
were performed for 40 cycles with cycling conditions of 15 s at
95 1C and 1 min at 60 1C. In vitro-transcribed CSFV RNA of known
concentrations were run in parallel reactions, used to generate a
standard curve.
Transfection and preparation of eukaryotic expression vectors
To construct eukaryotic protein expression vectors, the sequences
encoding WT or mutant NS5A were obtained by PCR from the
corresponding prokaryotic expression vectors and cloned into the
pcDNA-3.1 vector (Clontech) (Xiao et al., 2003; Xiao et al., 2009). The
inserted regions of all clones were sequenced through dideoxynu-
cleotide sequencing and no changes were found. The PK-15 cells, the
natural host of CSFV, were obtained from the China Center for Type
Culture Collection, Wuhan. The cells were cultured in DMEM (Gibco
BRL) supplemented with 10% fetal calf serum, penicillin (100 U/mL)
and streptomycin (100 mg/mL) at 37 1C in a humidiﬁed 5% CO2
atmosphere. Transfection of protein expression vectors was carried
out with a suspension of PK-15 cells following the instruction
manual for LipofectAMINETM2000 Reagent (Gibco). Cell culture
(3105 cells) was transfected with 50 mL Dulbecco’s modiﬁed
Eagle’s medium (DMEM) without serum containing 1 mg RNA or
the indicated concentration of protein expression vectors, and mixed
Fig. 11. The effect of key amino acid substitutions in NS5A on viral RNA replication. (A) The constructs used in the experiment. CSM- was generated through in-frame
deletion of a region encoding acid residues 240–247 of core protein in the complete genome RNA replicons, SM (Sheng et al., 2010). The proteins are shown over the CSM
subgenomic replicon. CSM- represents the CSM subgenomic replicon with markers produced by site-directed mutagenesis (G9973A, C9976T, at nucleotide level) (Sheng
et al., 2010). CSM-W143A, CSM-V145A, CSM-P227A, CSM-T246A, CSM-P257A, CSM-K399A, CSM-T401A, CSM-E406A and CSM-L413A represent the CSM subgenomic
replicon, produced by replacing corresponding amino acids of NS5A with a single alanine, indicated by arrows. (B) Viral RNA detected in PK15 cells transfected by different
CSFV subgenomic replicons. Total cellular RNA was extracted from the transfected PK15 cells at the indicated time points. Quantiﬁcation of viral RNA was determined by
using real-time PCR. The CSM subgenomic replicon was used to normalize the data obtained with the other subgenomic replicons. The amount of CSFV RNA in each sample
was divided by the amount detected in cells containing the CSM subgenomic replicon under the same conditions to obtain relative replication efﬁciencies. Results are
shown as means7SD of at least three independent transfections. (C) Viral RNA detected in PK15 cells transfected by different CSFV subgenomic replicons together with
pcDNA3.1/N-FLAG-NS5A vectors (Sheng et al., 2012). Quantiﬁcation of viral RNA was determined by using real-time PCR as described above.
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2000. After incubation at room temperature for 20 min, the com-
plexes were directly added to a well with cell culture. The plates with
the complexes were incubated in a CO2 incubator at 37 1C.
RNA preparation
The CSFV 30UTR (nt 1–231) was prepared as described pre-
viously (Xiao et al., 2006). RNA1, a 603 nt RNA template consist-
ing of the full-length CSFV 30UTR and the subsequent coding
sequence, was prepared as described previously (Xiao et al.,
2004). To form RNA2, the cDNA fragments of the 393 nt RNA
consisting of the full-length CSFV 50UTR, the subsequent coding
sequence and the 603 nt RNA with 30UTR were cloned into the
pGEM-T vector (Promega) from the CSFV RNA genome (SM,
Fig. 1A) by RT-PCR. The T7 promoter sequence was ligated to
the ﬁrst nucleotide of the 50UTR. The expected cDNA fragments
were cloned into the pGEM-T vector (Promega). After plasmids
were extracted and sequenced, the corresponding RNAs were
synthesized by PCR and subsequent in vitro transcription. In vitro
transcription was performed following a standard method in a
50 mL reaction mixture containing 20 mL 5 transcription buffer,
2 mL RNasin (20–40 U mL1; Promega), 5 mL each NTP (2.5 mM),
5 mL template and 2 mL T7 RNA polymerase (10–20 U mL1;
Promega). The mixture was incubated at 37 1C for 2 h. Ten
microlitres of DNase I (5 U mL1; Takara) was added to the
mixture and incubated at 37 1C for 15 min. The mixture was
extracted with phenol/chloroform/isoamyl alcohol. After
ethanol precipitation, the RNA was dried and dissolved in 20 mL
double distilled water. The integrity of the RNA was analyzed
by denaturing formaldehyde/agarose gel electrophoresis. Theconcentration of RNA was determined by measuring its absor-
bance at 260 nm.
GST pull-down assays
GST pull-down assays were performed as previously described
(Wang et al., 2011). Approximately 2 mg of GST, GST-NS5B fusion
protein immobilised on 20 mL of GST resin was pre-blocked with
1% bovine serum albumin and then incubated with 2 mg of WT or
mutant NS5A in 300 mL of PBST buffer (phosphate-buffered saline
containing 1% Triton X-100) for 3 h on a rotating device at room
temperature. After washing with PBST, the bound proteins were
fractionated by SDS-PAGE (10%) and subjected to Western blot
analysis with anti-NS5A antibody.
Co-immunoprecipitation analysis
Immunoprecipitation analyses were performed as previously
described (Wang et al., 2011). For immunoprecipitation analyses,
the sequences encoding WT and mutant NS5A were obtained by
PCR from the pET28 (a) vectors containing these protein-encoding
regions used for above prokaryotic expression, cloned into a
pcDNA3.1/N-FLAG vector. The inserted regions of all clones were
sequenced through dideoxynucleotide sequencing and no changes
were found. The resulting recombinant vectors, together with the
pcDNA3.1 vector containing NS5B, were used for co-transfection of
PK-15 cells by using LipofectAMINETM2000. PK-15 cells transfected
with the above plasmids were harvested, washed and sonicated in
RIPA buffer consisting of 150 mM NaCl, 0.5% Triton X-100, 10 mM
Triton–HCl (pH 7.5). Lysates were centrifuged at 12,000 g for
10 min at 4 1C and the supernatants was immunoprecipitated with
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20 mL protein G-agarose beads (Pharmacia) at 4 1C for 1 h. After
washing with RIPA buffer, the bound proteins were eluted, fractio-
nated by 10% SDS-PAGE, transferred onto nitrocellulose membranes,
and subjected to Western blot analysis with anti-FLAG monoclonal
antibody or anti-NS5B antibody. Protein bands were visualized by
enhanced chemiluminescence according to the manufacturer’s
instructions (Amersham Pharmacia Biotech).
Afﬁnity chromatography with biotinylated RNAs
Biotinylated full-length 30UTR fragments (nt 1–231) were
generated as above, except with the addition of Bio-11-UTP
(Perkin-Elmer) to the in vitro transcription reaction mixtures.
An irrelevant biotinylated RNA was obtained with an random
sequence corresponding to positions 1245–1700 of the CSFV plus-
strand genome as templates. Cytoplasmic extracts of PK15 cells
transfected with CSFV subgenomic replicons CSM (Sheng et al.,
2010) was pre-cleared by streptavidinagarose resin (Sigma).
Afﬁnity chromatography with biotinylated RNAs was performed
as described previously with slight modiﬁcations (Zhu et al.,
2010). In brief, the biotinylated RNAs (15 mg) were incubated
with streptavidin-agarose resin (Sigma) at 4 1C for 2 h in the
presence of incubation buffer (10 mM Tris–Cl [pH 7.5], 150 mM
KCl, 1.5 mM MgCl2, 0.5 mM DTT, 0.5 mM PMSF, and 0.05% Non-
idet P-40), and washed two times with incubation buffer. The pre-
cleared PK-15 extracts (500 mg) and yeast tRNA (30 mg, Roche)
were added to the resin, which was incubated for 30 min at room
temperature and then for 2 h at 4 1C. The resin was then washed
four times with incubation buffer, and the resin-bound proteins
were fractionated by SDS-PAGE (10%), transferred onto nitrocel-
lulose membranes, and subjected to Western blot analysis.
UV-crosslinking assays
Biotinylated RNAs were used in UV-crosslinking assays. Bioti-
nylated RNAs (5 ng) were incubated with 20 mg of cytoplasmic
extracts of PK15 cells transfected with NS5A (WT or mutants)-
expressing vectors (0.8 mg) or 100 ng of puriﬁed NS5A (WT or
mutants) for 10 min at 4 1C in a binding buffer of the following
composition in a total volume of 30 mL: 0.5 mM DTT, 5 mM HEPES
(pH 7.9), 75 mM KCl, 2 mM MgCl2, 0.1 mM EDTA, 4% glycerol,
20 U of RNasin (Promega), and 3 mg of yeast tRNA. And then, the
samples were irradiated with UV for 10 min with a UV-cross
linker (Stratalinker). RNase A (20 mg) was then added to the
reaction mixture for 30 min at 37 1C to digest unbound RNA.
Subsequently, the biotinylated RNA-protein complexes were
fractionated by SDS-PAGE (10%), and detected by Western blot
analysis or using the Bright Star Biodetect Kit (Ambion).
Preparation of CSFV genomic replicons and rescue of viruses
The CSFV genomic replicons SM and SM- with markers were
prepared as previously described (Sheng et al., 2010). A set of
overlapping cDNAs covering the whole genome were obtained by
RT-PCR (Fig. 9A), subsequently cloned into pGEM-T vector (Pro-
mega), respectively. These expected substitution mutations were
obtained from the cDNA6 clone in the context of genomic
SM- (Sheng et al., 2010). A SalI restriction site and the T7
promoter sequence were ligated to the ﬁrst nucleotide of 50UTR.
A unique SrfI site was engineered at the 30 terminus of CSFV
genome. Finally, the WT or mutant genomic cDNA was assembled
into the low-copy-number plasmid pBR322, respectively. The
plasmid containing the full-length and mutant genomic cDNA
was linearized with SrfI, and puriﬁed by phenol extraction and
ethanol precipitation and dissolved in an appropriate volume ofRnase-free water. RNA transcription and transfection were per-
formed as described above.
Rescue of viruses was preformed as described previously
(Sheng et al., 2010). The transfected cells were frozen and thawed
for 3 times. Cell suspensions were clariﬁed by centrifugation at
5000g for 10 min at 4 1C. CSFV-speciﬁc fragments of the 30UTR
were characterized by RT-PCR. Furthermore, monolayers were
subjected to an indirect immunoﬂuorescence assay with CSFV-
speciﬁc E2 monoclonal antibody F48-3-10 (Weiland, E) and the
second antibody labeled by FITC was also performed to make sure
that viruses were rescued in cells.Acknowledgment
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